Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
New Post
Former oil and gas trader convicted in Connecticut of FCPA and money laundering violations
September 30, 2024
News Alert
John Deere reaches settlement with SEC resolving FCPA allegations
September 11, 2024
News Alert
DOJ issues declination with disgorgement letter to Boston Consulting Group for possible FCPA offenses
August 29, 2024
News Alert